Literature DB >> 22305376

The Fourth INTERMACS Annual Report: 4,000 implants and counting.

James K Kirklin1, David C Naftel, Robert L Kormos, Lynne W Stevenson, Francis D Pagani, Marissa A Miller, J Timothy Baldwin, James B Young.   

Abstract

The Fourth Annual Report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of patient and data collection. With more than 4,000 patients entered into the database, the evolution of pump technology, strategy at implant, and pre-implant patient profiles are chronicled. A risk factor analysis of the entire adult primary implant population is provided, and the recent composition of patient profiles is examined. Current actuarial survival with continuous-flow pumps exceeds 80% at 1 year and 70% at 2 years.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2012        PMID： 22305376     DOI： 10.1016/j.healun.2011.12.001

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


  81 in total

Review 1.  [Total artificial heart].

Authors:  H Antretter; J Dumfarth; D Höfer
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-08-22       Impact factor: 0.840

2.  Ventricular assist devices: initial orientation.

Authors:  Martin Schweiger; Hitendu Dave; Frithjof Lemme; Olga Romanchenko; Michael Hofmann; Michael Hübler
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

3.  Prevalence and prognostic importance of changes in renal function after mechanical circulatory support.

Authors:  Meredith A Brisco; Stephen E Kimmel; Steven G Coca; Mary E Putt; Mariell Jessup; Wilson W H Tang; Chirag R Parikh; Jeffrey M Testani
Journal:  Circ Heart Fail       Date:  2013-11-08       Impact factor: 8.790

4.  Predictors of hospital length of stay after implantation of a left ventricular assist device: an analysis of the INTERMACS registry.

Authors:  William G Cotts; Edwin C McGee; Susan L Myers; David C Naftel; James B Young; James K Kirklin; Kathleen L Grady
Journal:  J Heart Lung Transplant       Date:  2014-03-01       Impact factor: 10.247

5.  Paracorporeal ventricular assist device as a bridge to transplant candidacy in the era of implantable continuous-flow ventricular assist device.

Authors:  Hideaki Suwa; Osamu Seguchi; Tomoyuki Fujita; Yoshihiro Murata; Michinari Hieda; Takuya Watanabe; Takuma Sato; Haruki Sunami; Masanobu Yanase; Hiroki Hata; Takeshi Nakatani
Journal:  J Artif Organs       Date:  2013-10-06       Impact factor: 1.731

6.  Caring for a spouse with end-stage heart failure through implantation of a left ventricular assist device as destination therapy.

Authors:  Lisa A Kitko; Judith E Hupcey; Juliann H Gilchrist; John P Boehmer
Journal:  Heart Lung       Date:  2013-03-14       Impact factor: 2.210

Review 7.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

Review 8.  Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.

Authors:  Jerry D Estep; Arvind Bhimaraj; A M Cordero-Reyes; Brian Bruckner; Matthias Loebe; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Jul-Sep

9.  The impact of insurance and socioeconomic status on outcomes for patients with left ventricular assist devices.

Authors:  Sakima A Smith; Ayesha K Hasan; Philip F Binkley; Randi E Foraker
Journal:  J Surg Res       Date:  2014-05-09       Impact factor: 2.192

10.  Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.

Authors:  Daniel P Mulloy; Castigliano M Bhamidipati; Matthew L Stone; Gorav Ailawadi; Irving L Kron; John A Kern
Journal:  J Thorac Cardiovasc Surg       Date:  2012-12-13       Impact factor: 5.209
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.